Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
---|
12/12/2000 | US6159443 X-ray guided drug delivery |
12/12/2000 | CA2168247C Nitric oxide donor composition and method for treatment of anal disorders |
12/11/2000 | CA2274419A1 Use of complexes among cationic liposomes and polydeoxyribonucleotides as medicaments |
12/07/2000 | WO2000073469A2 Protein kinases |
12/07/2000 | WO2000073450A2 Cytoskeleton-associated proteins |
12/07/2000 | WO2000073449A1 Dna encoding snorf33 receptor |
12/07/2000 | WO2000073448A1 Adipocyte complement related protein homolog zacrp7 |
12/07/2000 | WO2000073445A2 Interleukin-1-receptor associated kinase-3 (irak3) |
12/07/2000 | WO2000073444A1 Adipocyte complement related protein homolog zacrp5 |
12/07/2000 | WO2000073342A1 Structural models for cytoplasmic domains of transmembrane receptors |
12/07/2000 | WO2000073323A2 Adam polynucleotides and polypeptides |
12/07/2000 | WO2000073321A1 Human tumor necrosis factor receptor tr10 |
12/07/2000 | WO2000073313A1 New tricyclic amidine derivatives as inhibitors of nitric oxide synthase |
12/07/2000 | WO2000073307A2 Substituted 8-phenylxanthines useful as antagonists of a2b adenosine receptors |
12/07/2000 | WO2000073306A1 2-arylpurine-9-acetamide derivatives, process for the preparation thereof, medicinal compositions containing the same and intermediates of the derivatives |
12/07/2000 | WO2000073302A1 Oxazaheterocycles as protease inhibitors |
12/07/2000 | WO2000073298A1 Mutual prodrugs of amlodipine and atorvastatin |
12/07/2000 | WO2000073295A1 3-(arylsulfonylamino)-tetrahydropyran-3-carboxylic acid hydroxamides |
12/07/2000 | WO2000073294A2 3-(arylsulfonylamino)-tetrahydrofuran-3-carboxylic acid hydroxamides |
12/07/2000 | WO2000073282A1 Il-8 receptor antagonists |
12/07/2000 | WO2000073279A1 4-phenyl-pyrimidine derivatives |
12/07/2000 | WO2000073278A2 5-phenyl-pyrimidine derivatives |
12/07/2000 | WO2000073276A2 Carboxylic acid derivatives comprising aryl-substituted nitrogen heterocycles, their production and their use as endothelin receptor antagonists |
12/07/2000 | WO2000073275A1 Substituted phenylcyclohexane carboxylic acid amides that have an adenosine uptake inhibiting effect |
12/07/2000 | WO2000073274A2 Substituted phenylcyclohexane carboxylic acid amides and their use as adenosine uptake inhibitors |
12/07/2000 | WO2000073271A1 Mutual salt of amlodipine and atorvastatin |
12/07/2000 | WO2000073266A1 Novel antioxidants, preparation methods and uses |
12/07/2000 | WO2000073253A1 NOVEL INTERLEUKIN-1 AND TUMOR NECROSIS FACTOR-α MODULATORS, SYNTHESES OF SAID MODULATORS AND METHODS OF USING SAID MODULATORS |
12/07/2000 | WO2000072881A1 A blocking monoclonal antibody to vla-1 and its use for the treatment of inflammatory disorders |
12/07/2000 | WO2000072861A1 Pharmaceutical preparations of bioactive substances extracted from natural sources |
12/07/2000 | WO2000072845A1 Il-8 receptor antagonists |
12/07/2000 | WO2000072840A1 Il-8 receptor antagonists |
12/07/2000 | WO2000072826A1 Formulation and method for preparing elementary units from fermented drink |
12/07/2000 | WO2000072821A1 Generation of therapeutic microfoam |
12/07/2000 | WO2000072815A1 Indole derivatives |
12/07/2000 | WO2000072801A2 Alpha v integrin receptor antagonists |
12/07/2000 | WO2000046391A3 Genes displaying enhanced expression during cellular senescence and terminal cell differentiation and uses thereof |
12/07/2000 | DE19924892A1 Neue Carbonsäurederivate mit arylsubstituierten Stickstoffheterocyclen, ihre Herstellung und Verwendung als Endothelin Rezeptorantagonisten New carboxylic acid derivatives with aryl-substituted nitrogen heterocycles, their preparation and use as endothelin receptor antagonists |
12/07/2000 | DE19919585A1 Verwendung von Phyllanthus zur Behandlung von oxidativem Streß und anderen Symptomen Use of Phyllanthus for the treatment of oxidative stress and other symptoms |
12/07/2000 | CA2414094A1 Pharmaceutical preparations of bioactive substances extracted from natural sources |
12/07/2000 | CA2383244A1 Protein kinases |
12/07/2000 | CA2378737A1 Adipocyte complement related protein homolog zacrp5 |
12/07/2000 | CA2376116A1 Promotion or inhibition of angiogenesis and cardiovascularization |
12/07/2000 | CA2375827A1 A blocking monoclonal antibody to vla-1 and its use for the treatment of inflammatory disorders |
12/07/2000 | CA2375683A1 Il-8 receptor antagonists |
12/07/2000 | CA2375666A1 Novel carboxylic acid derivatives comprising aryl-substituted nitrogen heterocycles, their production and their use as endothelin receptor antagonists |
12/07/2000 | CA2375348A1 Novel antioxidants, preparation methods and uses |
12/07/2000 | CA2375188A1 Substituted phenylcyclohexane carboxylic acid amides and their use as adenosine uptake inhibitors |
12/07/2000 | CA2375186A1 Substituted phenylcyclohexane carboxylic acid amides that have an adenosine uptake inhibiting effect |
12/07/2000 | CA2375047A1 Dna encoding snorf33 receptor |
12/07/2000 | CA2374387A1 Adipocyte complement related protein homolog zacrp7 |
12/07/2000 | CA2374295A1 Il-8 receptor antagonists |
12/07/2000 | CA2374222A1 Cytoskeleton-associated proteins |
12/07/2000 | CA2374133A1 Structural models for cytoplasmic domains of transmembrane receptors |
12/07/2000 | CA2373937A1 Alpha v integrin receptor antagonists |
12/07/2000 | CA2373638A1 Adam polynucleotides and polypeptides |
12/07/2000 | CA2372246A1 Human tumor necrosis factor receptor tr10 |
12/07/2000 | CA2372234A1 Oxazaheterocycles as protease inhibitors |
12/07/2000 | CA2370598A1 Substituted 8-phenylxanthines useful as antagonists of a2b adenosine receptors |
12/06/2000 | EP1057826A1 Substituted dimeric carboxamide derivatives, method for preparing them, and pharmaceutical compositions containing them |
12/06/2000 | EP1057489A1 Preventives or remedies for ischemic diseases |
12/06/2000 | EP1057480A2 Transdermal estrogen agonist-antagonist therapy |
12/06/2000 | EP1056854A2 Protease-activated receptor 4 and uses thereof |
12/06/2000 | EP1056839A1 Pharmaceutical formulation containing a microbial enzyme which digests hyaluronic acid |
12/06/2000 | EP1056754A1 Phosphate derivatives of diaryl 1,3,4-oxadiazolone |
12/06/2000 | EP1056749A1 NOVEL TRIAZOLO(4,5-d)PYRIMIDINE COMPOUNDS |
12/06/2000 | EP1056743A1 Benzamine derivatives |
12/06/2000 | EP1056731A1 Amino acid derivatives of daryl 1,3,4-oxadiazolone |
12/06/2000 | EP1056730A1 Benzoate derivatives of diaryl 1,3,4-oxadiazolone |
12/06/2000 | EP1056729A1 N-[(substituted five-membered di- or triaza diunsaturated ring)carbonyl]guanidine derivatives for the treatment of ischemia |
12/06/2000 | EP1056701A1 E-2- 4-(4-chloro-1,2-diphenyl-but-1-enyl)phenoxy]ethanol and pharmaceutical compositions thereof |
12/06/2000 | EP1056462A1 Use of rhamnolipids in wound healing, treating burn shock, atherosclerosis, organ transplants, depression, schizophrenia and cosmetics |
12/06/2000 | EP1056455A1 Epimorphian compound and its use |
12/06/2000 | EP1056452A1 Indole-3-propionic acids, salts and esters thereof used as medicaments |
12/06/2000 | EP1056451A1 Bicyclic pyrrole derivatives as mcp-1 inhibitors |
12/06/2000 | EP1056449A2 20-hete antagonists and agonists |
12/06/2000 | CN1275981A Novel pharmaceutically active compounds, their preparation and use as ECE-inhibitors |
12/06/2000 | CN1275916A Method for keeping the quality of aqueous parenteral solution of thrombomodulin in storage and distribution |
12/06/2000 | CN1275389A Traditional Chinese medicine health care pillow |
12/06/2000 | CN1275388A Traditional Chinese medicine composition for treating ischemic encephalopathy and preparation process thereof |
12/06/2000 | CN1275382A Ointment for treating hemorrhoid complicated by anal fistula and its preparation method |
12/06/2000 | CN1275346A Method and equipment for destructive distillation of haw kernel to extract juice |
12/06/2000 | CN1059210C Process for preparation of 6-heterocyclic-4-amino-1,3,4,5-tetrahydrbenz [cd] indoles and acid additive salt used as medicine |
12/06/2000 | CN1059123C Medicine for treating cerebral apoplexy |
12/06/2000 | CN1059103C High-effective Naoxinning medicine for treating cardio-cerebral disease |
12/05/2000 | US6156881 Inhibition of cell adhesion protein-carbohydrate interactions |
12/05/2000 | US6156802 Cholesterol-lowering composition |
12/05/2000 | US6156800 Drugs for cardiovascular disorders and hypotensive agents |
12/05/2000 | US6156794 Nervous system disorders or alzheimers disease |
12/05/2000 | US6156788 Polycyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof |
12/05/2000 | US6156783 Spiroazabicyclic compounds, processes for their preparation, and their pharmaceutical use |
12/05/2000 | US6156766 Heterocyclic benzamides as drugs |
12/05/2000 | US6156757 1,2,3,4-tetrahydro-benzofuro[3,2-C]pyridine derivatives |
12/05/2000 | US6156756 Anticoagulants |
12/05/2000 | US6156752 Optically active 1,4-dihydropyridine compounds as bradykinin antagonists |
12/05/2000 | US6156750 Bioactive bicyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof |
12/05/2000 | US6156747 Psychological, gastrointestinal, cardiovascular disorders |
12/05/2000 | US6156741 Nervous system disorders |
12/05/2000 | US6156736 Gene transcription and ionizing radiation: methods and compositions |
12/05/2000 | US6156735 Arginine silicate inositol complex and use thereof |